Back to search

Article

Evaluation of 95-Gene Classifier of Formalin-Fixed Paraffin-Embedded Tissues in ER-Positive, HER2-Negative, and Node-Negative Breast Cancer

2021-05-04

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>A subset of patients with estrogen receptor (ER)-positive, HER2-negative, and node-negative breast cancer experience recurrences. Predicting patients who will have recurrences within 5 years of surgery is essential so that patients can be selected to receive adjuvant chemotherapy. The 95-gene classifier (95-GC) has been validated as a method to differentiate pati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bc1c72b0-20db-56bd-a132-e30136be1d7c
DOI
10.21203/rs.3.rs-436012/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of 95-Gene Classifier of Formalin-Fixed Paraffin-Embedded Tissues in ER-Positive, HER2-Negative, and Node-Negative Breast CancerDOI 10.21203/rs.3.rs-436012/v1
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies.Semantic proximity
A 95-gene Signature Stratifies Recurrence Risk of Invasive Disease in ER-positive, HER2-negative, Node-negative Breast Cancer With Intermediate 21-gene Signature Recurrence ScoresSemantic proximity
Integration of gene expression profiling and mutation analysis via RNA sequencing: transitioning the 95-gene classifier to a next-generation platform in early-stage HR+/HER2- breast cancer.Semantic proximity
The Early-Stage Triple-Negative Breast Cancer Landscape Derives a Novel Prognostic Signature and Therapeutic TargetSemantic proximity
Transcriptome Analysis Derives a Novel Prognostic 7-mRNA Signature in Early-Stage Triple-Negative Breast CancerSemantic proximity
Clinical and Molecular Characteristics of ER-Positive Breast Cancer Tumors Identified as Ultralow Risk by the 70-Gene Signature in a Randomized Clinical TrialSemantic proximity
Comparison of time-varying recurrence patterns in breast cancer patients with different molecular subtypes treated from 2008 to 2012 and from 2013 to 2016: a single-center retrospective studySemantic proximity
Deciphering the recurrence-associated coding and non-coding genes in triple-negative breast cancer using an integrated omics approachSemantic proximity
PreciseBreast is prognostic for breast cancer recurrence in a 21-gene assay managed cohortSemantic proximity
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signatureSemantic proximity
High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancerSemantic proximity
Comparative Evaluation of a 28-Gene versus 70-Gene Panel for Recurrence Risk Prediction in Early-Stage HR-Positive/HER2-Negative Breast Cancer in Chinese WomenSemantic proximity
Select a neighboring publication to make it the new centre.